Bluejay Diagnostics Inc (BJDX)

$1.57 -0.04 (-2.48%)
Market Cap 2.41M
Revenue (ttm) 0.00
Net Income (ttm) -7.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 24,100
Avg Vol 871,176
Day's Range N/A - N/A
Shares Out 1.49M
Stochastic %K 11%
Beta 0.47
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the compa...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
Putnik
Putnik Jul. 18 at 3:33 AM
$BJDX come on go over $2 already lol
0 · Reply
SmartBetting
SmartBetting Jul. 16 at 7:05 AM
$BJDX goodmorning goodluck.
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 3:38 PM
$BJDX added more
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 2:51 PM
$BJDX someone is accummulating !! 🚀🚀🚀
0 · Reply
Zeiliudge
Zeiliudge Jul. 15 at 2:47 PM
$BJDX it’s about time 🚀
0 · Reply
Zeiliudge
Zeiliudge Jul. 15 at 2:46 PM
$BJDX 👀🤑
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 2:04 PM
$BJDX 🚀🚀🚀
0 · Reply
The_OG_Stocktwit
The_OG_Stocktwit Jul. 15 at 3:11 AM
$BJDX gonna do the thing
0 · Reply
SmartBetting
SmartBetting Jul. 15 at 1:23 AM
$BJDX goodmorning~goodluck.
0 · Reply
Putnik
Putnik Jul. 11 at 11:30 PM
$BJDX when $2.50?
0 · Reply
Latest News on BJDX
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 6 weeks ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 3 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 3 months ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 8 months ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 1 year ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 1 year ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 1 year ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 1 year ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 1 year ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 1 year ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 2 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 2 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Sep 8, 2022, 9:33 AM EDT - 3 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

BSGM STSS

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Why Bluejay Diagnostics Shares Are Surging Higher Today

Jun 9, 2022, 10:19 AM EDT - 3 years ago

Why Bluejay Diagnostics Shares Are Surging Higher Today

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Putnik
Putnik Jul. 18 at 3:33 AM
$BJDX come on go over $2 already lol
0 · Reply
SmartBetting
SmartBetting Jul. 16 at 7:05 AM
$BJDX goodmorning goodluck.
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 3:38 PM
$BJDX added more
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 2:51 PM
$BJDX someone is accummulating !! 🚀🚀🚀
0 · Reply
Zeiliudge
Zeiliudge Jul. 15 at 2:47 PM
$BJDX it’s about time 🚀
0 · Reply
Zeiliudge
Zeiliudge Jul. 15 at 2:46 PM
$BJDX 👀🤑
0 · Reply
yoyohmm
yoyohmm Jul. 15 at 2:04 PM
$BJDX 🚀🚀🚀
0 · Reply
The_OG_Stocktwit
The_OG_Stocktwit Jul. 15 at 3:11 AM
$BJDX gonna do the thing
0 · Reply
SmartBetting
SmartBetting Jul. 15 at 1:23 AM
$BJDX goodmorning~goodluck.
0 · Reply
Putnik
Putnik Jul. 11 at 11:30 PM
$BJDX when $2.50?
0 · Reply
PierreleRat
PierreleRat Jul. 11 at 6:13 PM
$BJDX I can’t understand why the sentiment is bullish here
0 · Reply
Bikinibullshark
Bikinibullshark Jul. 10 at 1:36 PM
$BJDX someone said to buy this a while ago, I can’t remember who it was that recommended it. But it’s looking 👀 like time to start adding
0 · Reply
Putnik
Putnik Jul. 9 at 4:00 PM
$BJDX do they ever release good news? lol
0 · Reply
FinalWick
FinalWick Jul. 9 at 8:13 AM
Keep eyes on $APLM its got that look to it $LGHL $BULL $BJDX $SPY
0 · Reply
AsappTrading
AsappTrading Jul. 8 at 2:50 AM
$BJDX playing the ole average down game on this one until it pops over 2.00
0 · Reply
AsappTrading
AsappTrading Jul. 7 at 9:42 PM
$BJDX avg 1.76. I’m may average down one more time.
0 · Reply
RichieGreen
RichieGreen Jul. 2 at 11:32 PM
$BJDX any writhing here since one week ago. Now is time to buy
1 · Reply
PierreleRat
PierreleRat Jun. 26 at 2:13 PM
$BJDX does this have a 30% pop in the future? Maybe, maybe even probably….the real question is it gonna be before or after another precipitous crash. Daily, weekly, monthly charts all look like trash. Zoom out to the yearly and there’s nothing good about it. 🚩
0 · Reply
GDog877
GDog877 Jun. 26 at 12:10 PM
$BJDX this pos stock is a shorter's wet dream
0 · Reply
AsappTrading
AsappTrading Jun. 25 at 2:20 AM
$BJDX insider bar on the daily chart. Might have a bounce coming. Give me 2.25
1 · Reply
RetiredMilitary
RetiredMilitary Jun. 24 at 7:02 PM
$HYPD $TGE $BJDX $GLYC $KWE
0 · Reply
SwingNow
SwingNow Jun. 23 at 7:45 PM
$BJDX 100% move this week
1 · Reply